By Dani Blum The Food and Drug Administration on Wednesday declared an end to the two-year shortage of tirzepatide, the substance in the popular weight-loss medication Zepbound and the diabetes ...

Removal from the list would mean that pharmacies can no longer offer compounded versions of tirzepatide for the purpose of meeting demand due to the shortage. If the FDA were to eventually remove ...

Novo Nordisk's diabetes drug Ozempic isn't in short supply. However, shortages remain for the low-dose version of the weight-loss drug Wegovy, the FDA said. The FDA confirmed with Eli Lilly that ...

Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, freeing the company from competing with compounding pharmacies that have ...

The U.S.’s largest maker of intravenous fluids will slash shipments to hospitals after Hurricane Helene took down one of its manufacturing plants in North Carolina.

The Food and Drug Administration said late Wednesday that Lilly had resolved the shortage. It had started in 2022, just months after the drug was introduced with the brand Mounjaro for diabetes.

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been resolved. Tirzepatide, the active ingredient in the diabetes and ...

The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food and Drug Administration (FDA). The FDA updated its drug shortage ...

Contributing factors to the mechanic shortage include an aging workforce, lower-than-average earning potential and a rising number of older cars. While experts are divided over how long the ...

Dockworkers strike in a picket line outside of the Port of Houston Authority on October 01, 2024 in Houston, Texas. Photo: Getty Images U.S. ports from Maine to Texas shut down Tuesday when the ...

Rivian said on Friday it will build fewer vehicles this year than it did in 2023 due to a supply chain problem that popped up in the third quarter and has now “become more acute in recent weeks ...

What Dana Bash’s sources are telling her about Harris’ performance ...